Learn what’s trending by taking a look at last week’s most-viewed stories on Pharmaceutical Processing. No. 10 “France to Tighten Up Drug Trial Rules After Fatal Incident“ No. 9 “MilliporeSigma Wins Efficiency Champion Award at INTERPHEX 2016“ No. 8 “Best Practices for Pharmaceutical Waste“ No. 7 “FDA Recommends Approval of Sanofi’s Type 2 Diabetes Treatment“ No. 6…
Large Price Cuts on Three Top-Selling Drugs in China
On Friday, May 27, Chinese health authorities announced price cuts on three top-selling patented drugs of more than 50 percent, which is part of the Chinese government’s effort to make medicines more affordable. The three drugs and their reduced price tags are as follows: AstraZeneca‘s Iressa (gefitinib): dropping from 15,000 yuan ($2291) to 7,000 yuan ($1069) a month…
Novartis Splits Drug Division in Two
Novartis splits its Pharmaceutical Division into two business units: Novartis Pharmaceuticals and Novartis Oncology. On May 17, Novartis announced it was splitting its Pharmaceutical Division into two business units: Novartis Pharmaceutical and Novartis Oncology. This reorganization accounts for approximately two-thirds of the company’s $49 billion annual sales. Some reports claim that the restructure is partly in response to Novartis’…
What’s Hot in Pharma: 5/1/16 – 5/7/16
Valeant’s CEO Takes Medical Leave & Ex-CFO is Named Interim
Chief Executive Officer, Michael Pearson, of Valeant Pharmaceuticals International Inc. has taken a medical leave of absence. In his stead, the company has named former Chief Financial Officer, Howard Schiller, as the interim CEO, while Bob Ingram will take the place of interim chairman. Pearson has been hospitalized with severe pneumonia, and when he will return remains uncertain. The company officially disclosed…
New Pharma Manufacturing Portal in the UK
Proposal: Free Wi-Fi For Everyone Using the NHS
Patients, healthcare workers, and visitors alike should have access to free Wi-Fi while using the National Health Service (NHS)—or, so said Martha Lane Fox at Tuesday’s National Information Board (NIB) in the UK. According to one report on FirstWord Pharma, Fox—in response to the Health Secretary, Jeremy Hunt’s, question regarding practice proposals to the NIB on…